
Opinion|Videos|October 23, 2024
Unmet Needs and Future Research
Key Takeaways
- Understanding disease pathophysiology is essential for developing personalized treatment strategies and improving patient outcomes in type 2 inflammatory diseases.
- Identifying biomarkers can enhance disease monitoring and predict treatment responses, facilitating more effective management.
Panelists discuss how unmet needs in type 2 inflammatory diseases require further research, including developing more personalized treatment approaches, identifying novel biomarkers for better disease phenotyping, improving long-term disease control strategies, and addressing the psychosocial impacts of chronic inflammatory conditions to enhance patients’ overall quality of life and outcomes.
Advertisement
Episodes in this series

- What unmet needs require further research to improve quality of life and outcomes for patients living with type 2 inflammatory diseases?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Clinician Shortages, Access Gaps Challenge Rural Primary Care
3
Guselkumab Shows Sustained 48-Week Protection Against Joint Damage in PsA
4
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
5
















































